161 related articles for article (PubMed ID: 11765128)
21. Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models.
White HS; Scholl EA; Klein BD; Flynn SP; Pruess TH; Green BR; Zhang L; Bulaj G
Neurotherapeutics; 2009 Apr; 6(2):372-80. PubMed ID: 19332332
[TBL] [Abstract][Full Text] [Related]
22. Endocrine and gastrointestinal action of galanin.
Yanaihara N; Mochizuk T; Kuwahara A; Hoshino M; Kakuyama H; Iguchi K; Iwanaga T; Jun L; Futai Y; Kanno T; Yamabe K; Yanaihara C
Ann N Y Acad Sci; 1998 Dec; 863():129-42. PubMed ID: 9928166
[No Abstract] [Full Text] [Related]
23. Regulation of galanin in memory pathways.
Miller MA
Ann N Y Acad Sci; 1998 Dec; 863():323-41. PubMed ID: 9928181
[TBL] [Abstract][Full Text] [Related]
24. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
[TBL] [Abstract][Full Text] [Related]
25. The role of galanin as a multi-functional neuropeptide in the nervous system.
Wynick D; Thompson SW; McMahon SB
Curr Opin Pharmacol; 2001 Feb; 1(1):73-7. PubMed ID: 11712539
[TBL] [Abstract][Full Text] [Related]
26. Galanin modulates 5-hydroxytryptamine functions. Focus on galanin and galanin fragment/5-hydroxytryptamine1A receptor interactions in the brain.
Fuxe K; Jansson A; Diaz-Cabiale Z; Andersson A; Tinner B; Finnman UB; Misane I; Razani H; Wang FH; Agnati LF; Ogren SO
Ann N Y Acad Sci; 1998 Dec; 863():274-90. PubMed ID: 9928178
[TBL] [Abstract][Full Text] [Related]
27. Topiramate normalizes hippocampal NPY-LI in flinders sensitive line 'depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-inducing effects.
Husum H; Van Kammen D; Termeer E; Bolwig G; Mathé A
Neuropsychopharmacology; 2003 Jul; 28(7):1292-9. PubMed ID: 12700690
[TBL] [Abstract][Full Text] [Related]
28. Galanin expression within the basal forebrain in Alzheimer's disease. Comments on therapeutic potential.
Mufson EJ; Kahl U; Bowser R; Mash DC; Kordower JH; Deecher DC
Ann N Y Acad Sci; 1998 Dec; 863():291-304. PubMed ID: 9928179
[TBL] [Abstract][Full Text] [Related]
29. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease.
Lang R; Gundlach AL; Kofler B
Pharmacol Ther; 2007 Aug; 115(2):177-207. PubMed ID: 17604107
[TBL] [Abstract][Full Text] [Related]
30. Galanin and galanin receptors in embryonic stem cells: accidental or essential?
Tarasov KV; Tarasova YS; Crider DG; Anisimov SV; Wobus AM; Boheler KR
Neuropeptides; 2002 Aug; 36(4):239-45. PubMed ID: 12372696
[No Abstract] [Full Text] [Related]
31. Galanin and its receptors in neurological disorders.
Lundström L; Elmquist A; Bartfai T; Langel U
Neuromolecular Med; 2005; 7(1-2):157-80. PubMed ID: 16052044
[TBL] [Abstract][Full Text] [Related]
32. Neuroanatomical Localization of Galanin in Zebrafish Telencephalon and Anticonvulsant Effect of Galanin Overexpression.
Podlasz P; Jakimiuk A; Kasica-Jarosz N; Czaja K; Wasowicz K
ACS Chem Neurosci; 2018 Dec; 9(12):3049-3059. PubMed ID: 30095254
[TBL] [Abstract][Full Text] [Related]
33. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
[TBL] [Abstract][Full Text] [Related]
34. Galanin--a neuroendocrine peptide.
Bartfai T; Hökfelt T; Langel U
Crit Rev Neurobiol; 1993; 7(3-4):229-74. PubMed ID: 7693357
[TBL] [Abstract][Full Text] [Related]
35. Flufenamic acid suppresses epileptiform activity in hippocampus by reducing excitatory synaptic transmission and neuronal excitability.
Fernández M; Lao-Peregrín C; Martín ED
Epilepsia; 2010 Mar; 51(3):384-90. PubMed ID: 19732136
[TBL] [Abstract][Full Text] [Related]
36. Galanin receptor subtypes.
Branchek TA; Smith KE; Gerald C; Walker MW
Trends Pharmacol Sci; 2000 Mar; 21(3):109-17. PubMed ID: 10689365
[TBL] [Abstract][Full Text] [Related]
37. Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors.
Mazarati A; Lu X
Neuropeptides; 2005 Jun; 39(3):277-80. PubMed ID: 15944022
[TBL] [Abstract][Full Text] [Related]
38. Galanin: a significant role in depression?
Weiss JM; Bonsall RW; Demetrikopoulos MK; Emery MS; West CH
Ann N Y Acad Sci; 1998 Dec; 863():364-82. PubMed ID: 9928183
[TBL] [Abstract][Full Text] [Related]
39. Galanin receptor-1 knockout mice exhibit spontaneous epilepsy, abnormal EEGs and altered inhibition in the hippocampus.
McColl CD; Jacoby AS; Shine J; Iismaa TP; Bekkers JM
Neuropharmacology; 2006 Feb; 50(2):209-18. PubMed ID: 16243364
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the galanin system by repeated electroconvulsive seizures in mice.
Christiansen SH; Woldbye DP
J Neurosci Res; 2010 Dec; 88(16):3635-43. PubMed ID: 20936701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
